BioPharma Dive Feb 12, 2026 Lowering drug costs is on Republicans’ minds. Democrats say GOP policies don’t help.
10x Genomics Blog Feb 12, 2026 10X Genomics faces earnings test as new pricing strategy debuts - Investing.com
Cell Feb 12, 2026 CLIM-TIME identifies metastatic microenvironment modulators for T cell therapy response
Cell Feb 12, 2026 Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trial
FierceBiotech Feb 12, 2026 BridgeBio preps approval push after dwarfism drug increases children's height in phase 3
FierceBiotech Feb 12, 2026 Langer-backed biotech looks to end cancer recurrence with surgical revolution
FierceBiotech Feb 12, 2026 Agilent companion diagnostic lands FDA nod alongside Keytruda's latest cancer approval
FierceBiotech Feb 12, 2026 Seres to lay off 30% of employees, pause lead program in latest strategic shift
BioPharma Dive Feb 12, 2026 Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA chief Garijo